Internal Medicine · Tarzana, CA
NPI
1386679561
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5525 Etiwanda Ave., Suite 218
Tarzana, CA, 91356
Phone (818) 344-6111
Groups this clinician bills Medicare through
Medicare paid, 2024
$215K
2,296 services
Medicare patients, 2024
254
Average age 73
Drug cost, 2024
$579K
2,165 prescriptions
Company payments, 2025
$28.3
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey E Galpin was code 99215 (office e&m - established), 1,344 times for 247 patients. In total Jeffrey E Galpin billed 2,296 services in 7 codes, and Medicare paid $215K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 1,344 | 247 | $146.38 | $197K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 923 | 220 | $13.76 | $13K |
| 99205 Office E&M - New | Office | 22 | 22 | $172.40 | $3,793 |
By year: 2022 $204K for 1,454 services; 2023 $229K for 1,552 services; 2024 $215K for 2,296 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey E Galpin prescribed most often to Medicare patients was Alprazolam, with 110 prescriptions and refills. In total Jeffrey E Galpin wrote 2,165 Medicare prescriptions that cost $579K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 110 | 115 | 30 | $628 |
| Levothyroxine Sodium Generic | 66 | 128 | 22 | $800 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 59 | 59 | 16 | $1,353 |
| Lorazepam Generic | 59 | 62 | 16 | $346 |
| Rosuvastatin Calcium Generic | 57 | 125 | 18 | $570 |
| Escitalopram Oxalate Generic | 52 | 84 | 13 | $897 |
| Zolpidem Tartrate Er Zolpidem Tartrate | 46 | 46 | Under 11 | $646 |
| Atorvastatin Calcium Generic | 45 | 102 | 17 | $387 |
| Gabapentin Generic | 44 | 79 | 16 | $790 |
| Clonazepam Generic | 39 | 42 | Under 11 | $325 |
| Amlodipine Besylate Generic | 38 | 81 | 13 | $139 |
| Trazodone Hcl Generic | 38 | 54 | 12 | $182 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 36 | 36 | Under 11 | $142K |
| Metoprolol Succinate Generic | 36 | 80 | 16 | $406 |
| Synthroid Levothyroxine Sodium | 36 | 64 | 11 | $2,455 |
Brand drugs: - claims; generic drugs: 1,814 claims; opioid claims: 114.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey E Galpin $28.3 ($28.3 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $28.3.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $28.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.